Cercano Management’s Gilead Sciences GILD Stock Holding History

Cercano Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,300	Closed	-$541K	–	122
2022 Q4	$541K	Buy	+6,300	New	+$499K	0.02%	85

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cercano Management's GILD Position: Q1 2023 in Review

Cercano Management sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 6,300 shares — an estimated $541K sold.

Cercano Management first reported a position in GILD in Q4 2022 and held it in 1 quarter. The position peaked at $541K in Q4 2022. 1,736 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

Cercano Management reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
Cercano Management sold 6,300 Gilead Sciences shares in Q1 2023, an estimated $541K.
Cercano Management first reported a position in Gilead Sciences in Q4 2022 and held it in 1 quarter.
Cercano Management's Gilead Sciences position peaked at $541K in Q4 2022.
1,736 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Cercano Management's 13F filing for Q1 2023, filed 12 May 2023.